$1.17-1.68%
2026-10-07 closeSpero Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $48M. 2024 operating profit was −$73M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Spero Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $48M. 2024 operating profit was −$73M.